Cargando…

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate

Intraductal carcinoma of the prostate (IDC-P) is a rare and unique form of aggressive prostate carcinoma, which is characterized by an expansile proliferation of malignant prostatic epithelial cells within prostatic ducts or acini and the preservation of basal cell layers around the involved glands....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Minyong, Lee, Hyunwoo, Byeon, Sun-Ju, Kwon, Ghee Young, Jeon, Seong Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658449/ https://www.ncbi.nlm.nih.gov/pubmed/34884926 http://dx.doi.org/10.3390/ijms222313125

Ejemplares similares

Intraductal carcinoma of the prostate
por: Szentirmai, Eszter, et al.
Publicado: (2020)

Poly (ADP-ribose) polymerase inhibitor: A new horizon in advanced prostate cancer treatment
por: Kang, Minyong, et al.
Publicado: (2023)

Intraductal Carcinoma of the Prostate: To Grade or Not to Grade
por: Surintrspanont, Jerasit, et al.
Publicado: (2023)

Intraductal Carcinoma of the Prostate Gland: Recent Advances
por: Divatia, Mukul K., et al.
Publicado: (2016)

Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma
por: Jee, ByulA, et al.
Publicado: (2022)

Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review
por: Roberts, Jordan A., et al.
Publicado: (2013)

Intraductal carcinoma of the prostate: a critical re-appraisal
por: Varma, Murali, et al.
Publicado: (2019)

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study
por: Diop, Mame-Kany, et al.
Publicado: (2023)

Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas
por: Choi, Euno, et al.
Publicado: (2015)

Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer
por: Zhu, Sha, et al.
Publicado: (2019)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
por: Song, Wan, et al.
Publicado: (2019)

Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
por: Kim, Ryul, et al.
Publicado: (2022)

Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing
por: Kang, Minyong, et al.
Publicado: (2019)

Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait
por: Pantazopoulos, Helen, et al.
Publicado: (2022)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
por: Trinh, Vincent Q., et al.
Publicado: (2019)

Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate
por: Diop, Mame-Kany, et al.
Publicado: (2021)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component
por: de Brot, Simone, et al.
Publicado: (2021)

Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients
por: Yoon, Nara, et al.
Publicado: (2017)

Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5–10 ng/mL
por: Choi, Joongwon, et al.
Publicado: (2020)

Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma
por: Yoo, Gyu Sang, et al.
Publicado: (2022)

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
por: Böttcher, René, et al.
Publicado: (2018)

Intraductal oncocytic papillary neoplasm of the pancreas: clinical and radiological features compared to those of intraductal papillary mucinous neoplasm
por: Nakaya, Moto, et al.
Publicado: (2023)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
por: Lee, Chung-Un, et al.
Publicado: (2022)

New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles’ operation
por: Park, Byung Kwan, et al.
Publicado: (2023)

Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology
por: Shiomi, Ei, et al.
Publicado: (2022)

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
por: Zhu, Sha, et al.
Publicado: (2022)

Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy
por: Park, Jihwan, et al.
Publicado: (2021)

Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
por: Yu, Jiwoong, et al.
Publicado: (2021)

The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy
por: Zhao, Jinge, et al.
Publicado: (2017)

Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct
por: Jang, Gi-Woong, et al.
Publicado: (2012)

Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
por: Chung, Jae Hoon, et al.
Publicado: (2020)

Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists
por: Rho, Mi Jung, et al.
Publicado: (2022)

Predictive Features of Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis
por: Kwon, Wooil, et al.
Publicado: (2020)

Erratum: Correction of Author Name. Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review
por: Roberts, Jordan A., et al.
Publicado: (2013)

Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma
por: Tzelepi, Vasiliki, et al.
Publicado: (2021)

Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective Study
por: Hur, Joon Young, et al.
Publicado: (2019)

Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service
por: Rho, Mi Jung, et al.
Publicado: (2020)

Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6kn618emg5hqen719ba7vus0jj